De Pascale, Gennaro
 Distribuzione geografica
Continente #
EU - Europa 3.872
NA - Nord America 3.348
AS - Asia 1.314
SA - Sud America 50
AF - Africa 21
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.628
Nazione #
US - Stati Uniti d'America 3.313
DE - Germania 1.094
IT - Italia 742
SE - Svezia 675
CN - Cina 545
SG - Singapore 368
PL - Polonia 245
UA - Ucraina 222
IE - Irlanda 217
FR - Francia 200
GB - Regno Unito 137
ID - Indonesia 110
TR - Turchia 103
FI - Finlandia 101
IN - India 73
RU - Federazione Russa 67
BE - Belgio 32
HK - Hong Kong 32
NL - Olanda 27
CA - Canada 24
IR - Iran 23
ES - Italia 22
AU - Australia 16
CH - Svizzera 15
CO - Colombia 14
JP - Giappone 14
BR - Brasile 13
CZ - Repubblica Ceca 13
KR - Corea 13
AR - Argentina 10
VN - Vietnam 9
MX - Messico 8
CI - Costa d'Avorio 7
GR - Grecia 7
AT - Austria 6
CL - Cile 6
EG - Egitto 6
EU - Europa 6
LT - Lituania 6
MK - Macedonia 6
RO - Romania 6
BG - Bulgaria 5
EE - Estonia 5
PE - Perù 5
TW - Taiwan 5
VA - Santa Sede (Città del Vaticano) 5
PH - Filippine 4
PT - Portogallo 4
RS - Serbia 4
IL - Israele 3
NO - Norvegia 3
AF - Afghanistan, Repubblica islamica di 2
CR - Costa Rica 2
KZ - Kazakistan 2
MU - Mauritius 2
NG - Nigeria 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CM - Camerun 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 8.628
Città #
Chandler 702
Singapore 294
Ashburn 248
Dublin 216
Warsaw 210
Jacksonville 153
Ann Arbor 140
San Mateo 128
Nanjing 127
New York 117
Milan 114
Jakarta 109
Rome 99
Wilmington 89
Chicago 84
Dearborn 82
Fairfield 82
Nürnberg 80
Woodbridge 80
Seattle 69
Boston 64
Marseille 63
Izmir 62
Houston 61
Cattolica 56
Beijing 52
Moscow 51
Munich 51
Helsinki 50
Redwood City 49
Nanchang 48
Princeton 46
Lawrence 39
Los Angeles 38
Kraków 30
Bremen 29
Cambridge 28
Kunming 28
Boardman 27
Brussels 27
Redmond 23
Hangzhou 22
Hong Kong 22
Augusta 20
London 20
Norwalk 20
Padova 20
Pune 19
Hebei 18
Lancaster 18
Mountain View 18
Tianjin 18
Kocaeli 17
Shenyang 15
University Park 15
Changsha 14
Guangzhou 14
Jiaxing 13
Kish 13
Washington 13
Paris 12
San Diego 12
Verona 12
Brno 11
Falls Church 11
Leawood 11
Turin 11
Falkenstein 10
Shanghai 10
Zhengzhou 10
Hefei 9
Santa Clara 9
Seoul 9
Toronto 9
Zurich 9
Buenos Aires 8
Busto Arsizio 8
Jinan 8
Ottawa 8
Abidjan 7
Andover 7
Frankfurt am Main 7
Fremont 7
Renton 7
Brooklyn 6
Detroit 6
Lanzhou 6
Shawnee 6
Bologna 5
Clusone 5
Dong Ket 5
Edinburgh 5
Ferrara 5
Florence 5
Istanbul 5
Lappeenranta 5
Madrid 5
Monmouth Junction 5
Philadelphia 5
Santiago 5
Totale 4.780
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 311
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 242
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 220
Colistin use in critically ill patients: in search of the optimal dosing. 205
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 203
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 182
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 170
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 164
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 158
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 149
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 149
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 140
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 139
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 131
Neurological involvement during legionellosis, look beyond the lung 124
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 122
Data on the application of early coagulation support protocol in the management of major trauma patients 118
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 118
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 117
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 116
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 114
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 113
The importance of airway and lung microbiome in the critically ill 112
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 107
Neurological involvement during Legionellosis, look beyond the lung 104
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 103
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 102
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 101
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 99
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 99
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 95
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 89
Noninvasive ventilation for the immunocompromised patient: always appropriate? 87
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 87
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 87
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 85
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 82
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 81
Aerosolized colistin cost-effectiveness. Response 81
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 81
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 80
Sarilumab use in severe SARS-CoV-2 pneumonia 80
Lice, rodents, and many hopes: a rare disease in a young refugee 79
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 79
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 78
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 78
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 76
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 75
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 75
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 75
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 74
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 74
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 72
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 71
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 68
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 68
Dose of colistin: a work in progress? 68
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 68
The place of dexmedetomidine light sedation in patients with acute brain injury 68
Response 65
Fungal infections in the ICU: advances in treatment and diagnosis 65
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 65
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 65
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 60
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 59
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 59
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 57
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 57
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 55
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 54
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 54
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 53
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 53
Hemadsorption 52
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 51
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 51
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 50
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 49
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 48
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 48
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 47
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia 44
Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19 44
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study 43
How to manage aspergillosis in non-neutropenic intensive care unit patients 41
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 41
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 40
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 40
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 37
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 37
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia 37
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 36
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 33
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 31
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 30
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 29
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 29
Physiological effects of awake prone position in acute hypoxemic respiratory failure 26
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors 26
Totale 8.588
Categoria #
all - tutte 38.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020552 0 0 0 0 0 110 102 42 78 59 95 66
2020/2021798 37 68 23 54 81 64 103 31 98 54 135 50
2021/20221.092 90 73 67 68 84 57 24 162 59 71 163 174
2022/20232.120 228 264 134 287 143 233 105 201 246 107 108 64
2023/20241.330 78 274 63 58 67 195 96 93 40 74 140 152
2024/2025753 80 67 199 128 185 94 0 0 0 0 0 0
Totale 8.775